[A new molecule--international abbreviation metiazinic acid (chemical name: 10-Methyl-3-phenothiazinyl-acetic acid)--and its effect on rheumatic diseases].
D000085:Acetates / Q000009:adverse effects / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D016918:Arthritis, Reactive / Q000188:drug therapy; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D002908:Chronic Disease; D005260:Female; D006073:Gout / Q000188:drug therapy; D006801:Humans; D007592:Joint Diseases / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010640:Phenothiazines / Q000009:adverse effects / Q000627:therapeutic use*; D012019:Reflex Sympathetic Dystrophy / Q000188:drug therapy; D012216:Rheumatic Diseases / Q000188:drug therapy*; D013167:Spondylitis, Ankylosing / Q000188:drug therapy
D000085:Acetates; D010640:Phenothiazines
Ein neues Molekül--internationale Kurzebezeichnung Metiazinsäure (chemisch: 10-Methyl-3-Phenothiazinyl-Essigsäure)--und seine Wirksamkeit bei rheumatischen Erkrankungen.